Locations:

Tag: asco19

June 3, 2019/Cancer/Tumor Oncology

Rivaroxaban Reduces VTE in Patients with Pancreatic Cancer

Add prophylaxis for patients receiving systemic therapy

June 3, 2019/Cancer/News & Insight

Impact of Exercise and Demographics in Breast Cancer Survivors Over Age 65

Can exercise intervention reduce racial and socioeconomic disparities in health outcomes?

June 3, 2019/Cancer/Research

Could Immunotherapy Help Cure Cutaneous Squamous Cell Carcinoma?

Enroll patients now in KEYNOTE-630 trial

June 3, 2019/Cancer/Research

Low CD30 Expression in Non-Hodgkin’s Lymphoma Patients Does Not Predict Low Response to Brentuximab Vedotin

Study findings presented at ASCO 2019

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 3, 2019/Cancer/Research

New Renal Cancer Therapy Effective in Higher Risk Groups

Another option for immunotherapy

June 1, 2019/Cancer/Patient Support

Financial Navigator Support Pays Off for Cancer Patients and Providers

Reducing uncollectible revenue, financial burden

June 1, 2019/Cancer/Research

Optimal Total Dose of Cisplatin for High-Risk Oral Cavity Squamous Cell Carcinoma

It nearly doubles median disease-free survival

June 2, 2018/Cancer/Research

Immunotherapy Vaccine Improves Survival Rates in Patients with Glioblastoma

Drug stimulates an immune response to survivin

BackPage 1 of 1Next